Archive for the ‘About CBO’ Category

CBO Staff Gets Its Numbers Right in Charity Effort

Tuesday, June 23rd, 2009 by Douglas Elmendorf

While not working hard to produce estimates of varying kinds for the U.S Congress, the Congressional Budget Office’s staff often uses its formidable energies to help charitable organizations. As part of their ongoing commitment to the fight against breast cancer, members of our staff, friends, and family members participated in the Susan G. Komen Race for the Cure by walking or running the 5K race around the National Mall or by making pledges to the team or to individual team members. As a result of staff participation in fundraising, which included a CBO office bake sale, CBO was ranked number one in the Congressional category, surpassing 20 Congressional teams for top honors by raising a total of $3,578.50. CBO’s team was led by Simone Thomas, a CBO webmaster and cancer survivor, who has led annual efforts to raise funds for this important cause.

CBO is One of the Best Places to Work in the Federal Government

Wednesday, May 20th, 2009 by Douglas Elmendorf

I am delighted to announce that this morning CBO was recognized by the Partnership for Public Service as one of the “Best Places to Work in the Federal Government.”  CBO ranked third overall in the small agency category.

The Partnership uses the results of employee satisfaction surveys to evaluate agencies based on factors that create a positive work environment, such as employee skills/mission match, work/life balance, and effective leadership. Results for all participating federal agencies are available at  www.bestplacestowork.org. This was the first time CBO entered survey data in the rankings competition.

We credit these excellent results to our wonderful staff!  In spite of the pressures we face daily with the increasing legislative demands and turnaround times, in the end, it is the people, how we work together, and how we care about each other that define CBO.  I am so pleased that I have the good fortune to work with such terrific, dedicated, and intelligent colleagues.

CBO’s Climate Team

Monday, May 11th, 2009 by Douglas Elmendorf

Policymakers’ focus on climate change has shaped one of CBO’s principal areas of work.  Last week, I testified on the distribution of the costs of reducing carbon dioxide (CO2) emissions through a cap-and-trade system, and CBO issued a report on the potential impacts of climate change. Those are but the most recent contributions to CBO’s growing body of research on climate change issues, which includes work on the effect of climate change on the United States, options for reducing greenhouse-gas emissions, the effect of those options on different segments of our society, and the effect of proposed legislation on the federal budget.  All of CBO’s work on climate issues can be found on CBO’s Web site under the special section for climate change.

The publication of those products provides me with an opportunity to introduce to you the dedicated staff of budget analysts and economists at CBO who work on climate issues.  Analyzing the broad set of issues surrounding climate change truly requires a team effort that draws on a diverse set of skills and professional experiences.  Most of the formal training of the members of the climate team is in public policy analysis and economics. That formal training has been supplemented by many years of experience following developments in climate science, analyzing different policy options, and understanding the impacts of climate policy on different industries and parts of our economy.  The members of the team are:

Bruce Arnold
David Austin
Kim Cawley
Juan Contreras
Bob Dennis
Terry Dinan
Justin Falk
Ron Gecan
Teri Gullo
Dan Hoople
Joseph Kile
Rob Johansson
Mark Lasky
Susanne Mehlman
Ryan Miller
David Moore
Kevin Perese
Amy Petz
Frank Sammartino
Bob Shackleton
Natalie Tawil
Philip Webre
David Weiner

CBO’s Health Team

Tuesday, May 5th, 2009 by Douglas Elmendorf

Today’s Wall Street Journal quotes me saying that CBO has between 40 and 50 people working “more than full time” on health reform.  Yesterday’s Politico included me in an article about “Names, Faces to Watch for In Debate Over Care,” and the story referred to “Elmendorf and his team of anonymous analysts.”

Clearly, analyzing health reform proposals is a team effort. Indeed, projecting the behavioral consequences and budgetary impact of a variety of proposals to make major changes in a sector that accounts for one-sixth of the U.S. economy poses an enormous analytical challenge.  CBO is meeting that challenge because of the skill, knowledge, and hard work of our talented staff (and of our colleagues on the staff of the Joint Committee on Taxation, with whom we are collaborating in this effort). 

Because CBO believes that its estimating methodology should be as transparent as possible, perhaps our estimating team should be transparent as well.  In that spirit, here are the previously anonymous analysts at CBO who deserve a great deal of credit for their fine work analyzing health reform and related legislative proposals (I realize this list has more than 50 names; that’s because some of these people have other responsibilities beyond health reform):

Christi Anthony
David Auerbach
David Austin
Colin Baker
Elizabeth Bass
Jim Baumgardner
Patrick Bernhardt
Tom Bradley
Paul Burnham
Stephanie Cameron
Sheila Campbell
Jodi Capps
Michael Carpenter
Julia Christensen
Mindy Cohen
Anna Cook
Paul Cullinan
Sunita D’Monte
Noelia Duchovny
Sean Dunbar
Philip Ellis
Pete Fontaine
Carol Frost
Mike Gilmore
Matt Goldberg
Heidi Golding
April Grady
Stuart Hagen
Holly Harvey
Jean Hearne
Janet Holtzblatt
Lori Housman
Paul Jacobs
Sarah Jennings
Daniel Kao
Jamease Kowalczyk
Susan Labovich
Julie Lee
Leo Lex
Joyce Manchester
Kate Massey
Noah Meyerson
Alex Minicozzi
Carl Mueller
Carla Murray
Athiphat Muthitacharoen
Keisuke Nakagawa
Kirstin Nelson
Lyle Nelson
Andrea Noda
Ben Page
Allison Percy
Lisa Ramirez-Branum
Lara Robillard
Matt Schmidt
Kurt Seibert
Sven Sinclair
Julie Somers
Robert Stewart
Julie Topoleski
Bruce Vavrichek
David Weiner
Ellen Werble
Chapin White
Rebecca Yip

Panel of Economic Advisers

Friday, April 24th, 2009 by Douglas Elmendorf

CBO has a panel of economic advisers that includes many distinguished economists (some of whom are former CBO directors). We host periodic meetings of the advisers at our office and solicit the advisers’ views between meetings via email exchanges and phone calls. Through these interactions, we benefit from the advisers’ understanding of cutting-edge research, current economic conditions and the economic outlook, and the budget and economic policy process. As a result of the advisers’ comments, the quality of CBO’s economic analysis is greatly enhanced. The advisers for 2009 are:

Henry J. Aaron, Ph.D.
Senior Fellow
Brookings Institution

Martin N. Baily, Ph.D.
Senior Fellow
Brookings Institution

Richard Berner, Ph.D.
Managing Director
Chief U.S. Economist
Morgan Stanley

Martin Feldstein, Ph.D.
Professor of Economics
Harvard University

Kristin J. Forbes, Ph.D.
Professor of Economics
Sloan School of Management
Massachusetts Institute of Technology

Robert J. Gordon, Ph.D.
Professor of the Social Sciences
Northwestern University

Robert E. Hall, Ph.D.
Senior Fellow
Hoover Institution
Professor of Economics
Stanford University

Jan Hatzius, Ph.D.
Chief U.S. Economist
Goldman Sachs & Co.

Douglas Holtz-Eakin, Ph.D.
President
DHE Consulting, LLC

Simon Johnson, Ph.D.
Professor of Entrepreneurship
MIT-Sloan School of Management
Senior Fellow, Peterson Institute
for International Economics

Lawrence Katz, Ph.D.
Professor of Economics
Harvard University

Anil Kashyap, Ph.D.
Professor of Economics and Finance
Booth School of Business
University of Chicago

Laurence H. Meyer, Ph.D.
Distinguished Scholar
Center for Strategic and International Studies
Vice Chairman
Macroeconomic Advisers

William D. Nordhaus, Ph.D.
Professor of Economics
Professor, School of Forestry and
Environmental Studies
Yale University

Rudolph G. Penner, Ph.D.
Senior Fellow
Urban Institute

Adam S. Posen, Ph.D.
Deputy Director
Peter G. Peterson Institute
for International Economics

James Poterba, Ph.D.
Professor of Economics
Massachusetts Institute of Technology
President, NBER

Alice Rivlin, Ph.D.
Senior Fellow
Brookings Institution

Nouriel Roubini, Ph.D.
Professor of Economics and
International Business
Stern School of Business
New York University
Chairman
Roubini Global Economics

Diane C. Swonk, Ph.D.
Senior Managing Director
Chief Economist
Mesirow Financial

Stephen P. Zeldes, Ph.D.
Professor of Finance and Economics
Graduate School of Business
Columbia University

We appreciate these advisers’ contribution to our work, and we look forward to continuing to benefit from their knowledge and experience.

Panel of Health Advisers

Monday, April 20th, 2009 by Douglas Elmendorf

CBO has a panel of health advisers consisting of widely recognized experts in health policy. Members of the panel have a variety of backgrounds, areas of knowledge, and experience. We host periodic meetings of the advisers at our office and solicit their views between meetings via e-mail exchanges and conference calls. Through these interactions, we benefit from the advisers’ understanding of cutting-edge research and the latest developments in health care delivery and financing. As a result, the quality of CBO’s analysis of health policy is greatly enhanced. (The agency also has a panel of economic advisers, which I will discuss in an upcoming blog entry.) The health advisers for 2009 and 2010 are:

Joseph Antos, Ph.D.
Wilson H. Taylor Scholar in Health Care
and Retirement Policy
American Enterprise Institute

Katherine Baicker, Ph.D.
Professor of Health Economics
Department of Health Policy and Management
Harvard School of Public Health

John Bertko, F.S.A., M.A.A.A.
Adjunct Staff, RAND Corporation
Visiting Scholar, The Brookings Institution

Michael Chernew, Ph.D.
Professor
Department of Health Care Policy
Harvard Medical School

David Cutler, Ph.D.
Otto Eckstein Professor
of Applied Economics
Department of Economics, and Kennedy School of Government Harvard University

Karen Davis, Ph.D.
President
The Commonwealth Fund

Jose Escarce, M.D., Ph.D.
Senior Natural Scientist
RAND Corporation
Adjunct Professor of Health Services
School of Public Health
University of California, Los Angeles

Roger Feldman, Ph.D.
Blue Cross Professor of Health Insurance
Professor of Economics
University of Minnesota

Amy Finkelstein, Ph.D.
Assistant Professor of Economics
Massachusetts Institute of Technology

Alan M. Garber, M.D., Ph.D.
Staff Physician, Veterans Affairs
Palo Alto Health Care System
Henry J. Kaiser Jr. Professor of Medicine
Director, Center for Health Policy
Director, Center for Primary Care
and Outcomes Research
Stanford University

Paul Ginsburg, Ph.D.
President
Center for Studying Health System Change

Dana Goldman, Ph.D.
Director of Health Economics
RAND Chair in Health Economics
Senior Principal Researcher
RAND Corporation
Professor of Health Services and Radiology, UCLA

Jonathan Gruber, Ph.D.
Professor and Associate Head
Department of Economics
Massachusetts Institute of Technology

Thomas Lee, M.D.
Network President, Partners Healthcare Systems, Inc.
Professor of Medicine, Harvard Medical School
Professor of Health Policy and Management,
Harvard School of Public Health

Mark McClellan, M.D., Ph.D.
Senior Fellow and Director
Engelberg Center for Healthcare Reform  Leonard D. Schaeffer Director’s Chair in Health Policy Studies
Brookings Institution

Elizabeth McGlynn, Ph.D.
Associate Director, RAND Health
Distinguished Chair in Health Quality
Senior Principal Researcher
RAND Corporation

David Meltzer, M.D., Ph.D.
Associate Professor,
Department of Medicine,
Department of Economics, and
Graduate School of Public Policy Studies
University of Chicago

Joseph Newhouse, Ph.D.
John D. MacArthur Professor of
Health Policy and Management
Director, Division of Health Policy
Research and Education
Chair, Committee on Higher Degrees
in Health Policy
Harvard University

Mark Pauly, Ph.D.
Bendheim Professor of Health Care
Systems, Business and Public Policy,
Insurance and Risk Management,
and Economics
Wharton School
University of Pennsylvania

Robert Reischauer, Ph.D.
President
The Urban Institute

Jonathan Skinner, Ph.D.
John French Professor of Economics
Department of Economics
Dartmouth University
Professor of Community and
Family Medicine
Center for Evaluative Clinical Sciences
Dartmouth Medical School

We appreciate these advisers’ contribution to our work.  We look forward to continuing to benefit from their knowledge and experience as we undertake very complex analyses of proposals for major changes in the nation’s health care system.

Greetings

Monday, January 26th, 2009 by Douglas Elmendorf

Hello.  I’m Doug Elmendorf, the new director of the Congressional Budget Office.  I am honored to be appointed to this position and excited to be joining the talented and dedicated analysts here at CBO.

I want to begin by thanking Bob Sunshine, the deputy director of CBO, who has served as acting director since Peter Orszag resigned in November.  Bob has earned the admiration and appreciation of everyone at CBO for his dedicated service over many years and his sure-handed leadership during the past two months.

Perhaps I should tell you a little about me:  I have spent my career as an economist working on public policy.  After receiving my PhD at Harvard, I taught there for several years (including a course on American economic policy) and then moved to Washington.  My first job in Washington was as an analyst at CBO (and it’s great to be back).  Then, I worked in turn at the Federal Reserve Board, the White House Council of Economic Advisers, the Treasury Department, and again at the Federal Reserve.  Most recently, I was a senior fellow at the Brookings Institution.  In the course of these jobs and in my own research, I have spent a great deal of time thinking about budget policy, Social Security, Medicare, national health reform, the financial system, macroeconomic analysis and forecasting, economic volatility, and more.

More important, probably, is to remind you about the role of CBO.  Our mission is to provide information to the Congress to help it make effective budget and economic policy.  We are committed to providing information that is:

  • Objective – representing not our personal opinions but the consensus and diversity of views of experts from around the country;
  • Insightful – applying the best new evidence and innovative ideas as well as the lessons of experience;
  • Timely – responding as quickly as possible to the needs of the Congress; and 
  • Clearly presented and explained – so that policymakers and analysts understand the basis for our findings and have the opportunity to question our assumptions.

At this time of financial and economic crisis, and with many long-standing budgetary and economic challenges also demanding attention, policymakers will be making unusually difficult and consequential decisions.  We at CBO understand the responsibility we bear in this process and are looking forward to our further opportunity to assist the Congress in its efforts to enact good public policy.

By the way, many people have asked whether I intend to continue this blog, and I am happy to let you know that I will.  I hope the blog will continue to increase people’s understanding of our work at CBO.  Please keep reading.

 

 

Farewell

Tuesday, November 25th, 2008 by Bob Sunshine

CBO has been privileged, for the past two years, to have Peter Orszag as its Director.  During that time, he worked tirelessly to ensure that the Congress received the timely, high quality, budget and economic information and policy analysis that it needs to address the important public policy issues facing our nation.  He also expanded the agency’s focus on key areas like climate change and health care, with particular emphasis on the long-term fiscal threat posed by rising health care costs.  CBO’s work, under his leadership, was done, as always, in a scrupulously objective and nonpartisan manner. 

Peter’s broad knowledge, energy, wisdom, and dedication have been enormous assets to CBO, and the agency wishes him well as he begins the next phase of his career in public service.

Bob Sunshine, Acting Director

 

Life is a series of hellos and goodbyes: A final blog entry

Tuesday, November 25th, 2008 by Peter Orszag

Today President-elect Obama announced his intention to nominate me as director of the Office of Management and Budget.  I am therefore resigning as director of CBO and this will be my final blog entry.

I have absolutely loved my time at CBO.  CBO is unique because it combines rigor, relevance, and range.  Rigor reflects the intellectual integrity of what CBO does.  Relevance speaks to the importance of what it does.  And range reflects the wide array of topics upon which CBO has something important to say – from national security to labor markets to natural resources, health care, immigration, and the list goes on and on and on.  (This blog has also been a special treat: it has provided another way of discussing CBO’s work and some of my own views about the policy world.)

Perhaps most fundamentally, CBO is a reflection of the smart and hard-working but also warm and wonderful people who work here.  (If you find it hard to believe that budget analysts and economists can be warm and wonderful, please just take my word for it.) I have worked with many outstanding people in both the public sector and the private sector, and the CBO staff is truly exceptional in its analytical capability and its devotion to the work it does.   

I will very much miss CBO, and hope that I will do it proud if I am confirmed by the Senate to assume my new post.

Peter R. Orszag

Institute of Medicine of the National Academies, plus a related thought

Monday, October 13th, 2008 by Peter Orszag

The Institute of Medicine of the National Academies of Sciences announced its new members this morning. I’m quite honored to be included in this group — along with Jose Escarce, who is on CBO’s Panel of Health Advisers. I view my inclusion as testimony to what the outstanding CBO health staff has taught me about health care and health policy, and look forward to continuing to learn from them and other innovators in the field.

While I’m on the topic of health care, I’d like to make a point related to the current turmoil in financial markets. Many observers have noted that addressing the problems in financial markets and the risks to the economy may displace health care reform on the policy agenda — and that may well be the case for some period of time. (As a small example, I know that over the past few months I have been spending less time on health care because the turmoil in financial markets and associated issues have consumed much more of our time and attention at CBO. This displacement is a matter of finite time and energy, not budgetary resources.)

Although it may not seem immediately relevant given our current difficulties, it will be crucial to address the nation’s looming fiscal gap — which is driven primarily by rising health care costs — as the economy eventually recovers from this current downturn. Indeed, our ability to address our current economic difficulties (through both financial market interventions and potential additional fiscal stimulus) would be severely impaired if investors were not so willing to invest substantial sums in Treasury securities without charging much higher interest rates. That willingness reflects the (currently accurate) view among investors that Treasury securities are extremely safe investments.

If we fail to put the nation on a sounder fiscal course over the next few decades, though, we will ultimately reach a point where investors would lose confidence and no longer be as willing to purchase Treasury debt at anything but exorbitant interest rates. If that were to occur, we would lack the kind of maneuvering room that we currently enjoy to address problems in the financial markets and the economy. So if you think the current economic crisis is serious, and it is, imagine what it would be like if we didn’t have the ability to undertake aggressive and innovative policy interventions because creditors were effectively unwilling to lend substantial additional sums to the Federal government…